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Abstract
Varicella-zoster virus (VZV) is a neurotropic human alphaherpesvirus that causes varicella upon primary infection, establishes
latency in multiple ganglionic neurons, and can reactivate to cause zoster. Live attenuated VZV vaccines are available;
however, they can also establish latent infections and reactivate. Studies of VZV latency have been limited to the analyses of
human ganglia removed at autopsy, as the virus is strictly a human pathogen. Recently, terminally differentiated human
neurons have received much attention as a means to study the interaction between VZV and human neurons; however, the
short life-span of these cells in culture has limited their application. Herein, we describe the construction of a model of
normal human neural progenitor cells (NHNP) in tissue-like assemblies (TLAs), which can be successfully maintained for at
least 180 days in three-dimensional (3D) culture, and exhibit an expression profile similar to that of human trigeminal
ganglia. Infection of NHNP TLAs with cell-free VZV resulted in a persistent infection that was maintained for three months,
during which the virus genome remained stable. Immediate-early, early and late VZV genes were transcribed, and low-levels
of infectious VZV were recurrently detected in the culture supernatant. Our data suggest that NHNP TLAs are an effective
system to investigate long-term interactions of VZV with complex assemblies of human neuronal cells.
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Introduction
Varicella-zoster virus (VZV) is a ubiquitous human herpesvirus,
as evidenced by a seroprevalence of more than 95% worldwide
[1]. Among human herpesviruses, VZV has the smallest genome
of approximately 125 kbp, which contains at least 70 open reading
frames (ORFs) and consists of two unique regions, unique long
(UL) and unique short (US), each flanked by inverted repeat
regions (TRL, IRL, TRS, IRS) [2,3]. Primary VZV infection
typically causes childhood varicella (chickenpox). During primary
infection the virus gains access to and establishes latency in
multiple cranial, dorsal root and autonomic ganglia. Varicella
vaccination programs have successfully reduced the incidence of
clinical disease in children in the USA by about 80% [4,5];
however, the attenuated vaccine, like wild-type VZV, is still able to
establish latency in the peripheral nervous system [6]. Both wild-
type and vaccine virus can reactivate from latency, particularly in
elderly and immunocompromised individuals. Reactivation is
associated with a declining VZV specific T-cell immunity and can
result in herpes zoster (shingles) especially in the elderly, which is
characterized by severe pain and often followed by postherpetic
neuralgia [7,8]. Reactivation can also lead to progressive outer
retinal necrosis and stroke by ischemic vasculopathy [9,10]. With
respect to disease severity, duration and quality-of-life impairment,
VZV reactivation in adulthood can be more serious than primary
childhood infection.
VZV pathogenesis, latency, and reactivation are difficult to
study, as the virus exclusively infects humans and no animal model
is currently available to investigate VZV latency. As a result, our
knowledge of VZV latency is based on the analysis of human
ganglia removed at autopsy. However, primary human ganglia
have several disadvantages: (i) they can only be cultured for a few
days in vitro, (ii) the availability of human ganglia is limited, (iii) the
time between death and tissue collection cannot be predetermined,
(iv) there are considerable human to human variations including
preexisting virus burden and time since primary VZV infection,
and (v) since most ganglia explants contain latent VZV, it is
difficult to perform prospective studies using VZV with defined
genetic mutations. Therefore, our understanding of VZV latency
largely represents a snapshot of human ganglia that show a high
degree of variability [11] taken shortly after death.
Human fetal dorsal root ganglia (DRG) are typically free of
latent VZV. Enzymatically dissociated human DRG show neurite
outgrowth when maintained in culture and have facilitated the
analysis of apoptosis inhibition mediated by VZV in neurons
[12,13]; however, since the cultures can be maintained for only a
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few weeks, their application to study latent infection is limited.
Human fetal DRG can be maintained for eight weeks as
xenografts under the kidney capsule of SCID mice [14], and the
virus gene expression profile at eight weeks post-infection in DRG
xenografts is comparable to latently infected adult trigeminal
ganglia; however, difficulties in maintaining viable DGR xeno-
grafts along with ethical concerns regarding fetus-derived tissue
has limited their widespread utilization.
Human stem cells provide an alternative source of neurons.
Stem cell-derived neurospheres can be maintained in tissue culture
and in lateral ventricles of neonatal non-obese diabetic SCID
mice. While human neurospheres maintained in mice can be
infected with VZV and show no obvious virus-induced cytopathic
effect, time course experiments using this system are technically
challenging and costly [15]. In addition, differentiated human
pluripotent stem cells can be infected with VZV and are useful to
visualize retrograde virus axonal transport; however in these
cultures, VZV initiates lytic replication that appears to be related
to the neuronal purity [16,17,18]. Neuronal cultures lacking
significant numbers of glia or astrocytes can be infected, show no
virus-induced cytopathic effects (CPE) and do not produce
infectious virus; but, it is challenging to obtain these short-lived
cultures of pure neurons [19]. Taken together, the available
neuronal models to study VZV interactions are hindered by their
limited availability, elaborate maintenance requirements, limited
lifespan, neuronal purity and significant ethical concerns.
In order to overcome these problems, we developed a novel
three-dimensional (3D) culture system to maintain partially
differentiated normal human neural progenitor (NHNP) cells as
tissue-like assemblies (TLAs) that share some features with neurons
found in human trigeminal ganglia. The 3D NHNP TLAs can be
maintained for at least three months following VZV infection.
During this time, VZV DNA was readily detected, VZV
immediate-early, early and late genes were transcribed, no
VZV-induced CPE was observed, but low amounts of infectious
virus were released into the culture medium. Importantly, the
VZV genome was stable throughout the three month infection
period, suggesting that the 3D NHNP TLA culture system may be
useful to investigate the long-term interplay between VZV and
neural tissue.
Results
NHNP TLAs 3D cell cultures
NHNP cells were cultured in 3D on a scaffold of Cultispher
beads in a rotating wall vessel (RWV) bioreactor and analyzed by
multicolor fluorescence in situ hybridization (mFISH), flow
cytometry, confocal microscopy and RT-PCR to assess their
genetic stability as compared with 2D NHNP cell cultures.
Comparison of 2D and 3D cultured NHNP cells by mFISH
respectively showed no chromosomal rearrangements or breaks,
indicating genetic stability of NHNP TLAs for at least a six month
period in culture (Fig. 1A–B). Flow cytometry analysis confirmed
that after 180 days in culture, NHNP TLAs expressed neuronal
progenitor markers CXCR4, CD133, CD105-Endoglin, CD 90-
Thy-1 and CD49f-a6 Integrin at levels comparable to the parental
NHNP (2D) cell population (Table 1). Markers of hematopoietic
differentiation, CD38+ (Table 1) and CD45+ (data not shown)
were not detected in either culture. An example of the tissue-like
complexity of the NHNP TLA constructs is shown by environ-
mental scanning electron micrographs (ESEM) in Fig. 1C–F,
which illustrate the relative size, density, and indistinguishable
nature of the individual neural cells in the tissue assembly. In
addition, confocal microscopy confirmed that NHNP TLAs
expressed mature neuronal markers: neuron-specific nuclear
protein (NeuN), b-Tubulin-III, microtubule associated protein
A&B (MAP 2 A&B), and glial fibrillary acidic protein (GFAP)
(Fig. 2A). TLA microcarrier substrates alone did not show
autofluorescence (data not shown). Similarly, progenitor (Nestin)
and mature (b-Tubulin-III) neuronal markers were detected by
immunohistochemistry in human TG removed at autopsy
(Fig. 2B). Quantitative analysis of mRNA expression revealed
higher levels of the early progenitor markers CXCR4 and CD133
in NHNP TLAs than in human TG (Fig. 2C) even though only
few NHNP cells expressed the two proteins (Table 1). Later stage
developmental markers, CD105, CD90 and CD49f, were
expressed to a lesser extent in NHNP TLAs than in human TG,
suggesting that NHNP TLAs are less differentiated than primary
TGs. Neuronal markers Nestin and b-Tubulin-III were expressed
at comparable levels in TG and NHNP TLAs (Fig. 2C). Lower
expression levels in the NHNP TLAs than in human TG were
observed for the neuronal marker neurofilament 200 (NF-200),
again indicating NHNP TLAs are generally less differentiated than
human TG. Taken together, our data indicated that NHNP
TLAs, which had undergone 18–20 fold expansion over the three-
month time period, share some similarities but are less differen-
tiated when compared to mature human TGs removed at autopsy.
Generation and characterization of fluorescently-labeled
VZV
Both copies of the diploid VZV gene ORF63/70 encoding the
immediate-early protein 63 (IE63) were mutated to identify
expression originating from each gene. The fluorescent proteins
eGFP and mRFP were inserted at the C-terminus of ORF63 and
70, respectively, in the parental VZV Oka strain. For genetic
manipulations, an infectious BAC clone (pP-Oka) was used and
the insertion of the marker genes resulted in recombinant BAC
p63G/70R (Fig. 3A). Correct incorporation of eGFP and mRFP
coding sequences was confirmed by PCR, DNA sequencing and
multiple RFLP analyses (Fig. 3B). The p63G/70R BAC was then
transfected into MeWo cells, resulting in reconstitution of the
recombinant virus (v63G/70R). Upon virus reconstitution,
ORF63-eGFP and ORF70-mRFP expression was readily detected
in all plaques (Fig. 3C, upper panel), confirming that both loci
were expressed in infected MeWo cells. Upon subsequent passages
Author Summary
Varicella-zoster virus (VZV), the alphaherpesvirus that
typically causes childhood chickenpox and shingles in
adults, becomes latent in neurons, thus remaining in the
body for a lifetime. Unfortunately, few models are available
to study the establishment of VZV latency since the virus
infects only humans and establishes persistent infections
and latency only in neurons, a slowly proliferating, short-
lived cell in culture. We have successfully maintained
normal human neural progenitor cells (NHNP) in tissue-like
assemblies (TLAs) in 3-dimensional (3D) cultures for up to 6
months. The 3D NHNP TLAs show some characteristics as
those found in the human trigeminal ganglia, the site of
VZV latency. NHNP TLAs infected with VZV remain viable
for 3 months during which time VZV DNA replicates and
remains genetically stable, virus genes are transcribed, and
infectious VZV is sporadically released. The ability to
maintain VZV infected NHNP cells in culture for extended
times provides the unique opportunity to study the
molecular interactions between this important human
pathogen and neuronal tissue to an extent previously
unattainable.
Persistent VZV Infection in NHNP TLAs
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of v63G/70R, plaques developed in which only either eGFP or
mRFP were expressed (Fig. 3C, middle and lower panel),
suggesting that recombination between the IRS and TRS regions
had occurred. PCR analysis of multiple isolated plaques positive
for only eGFP or mRFP indicated homogeneity in the fluorescent
tag, thus confirming that both ORF63 and ORF70 contained the
same mutation (data not shown), and confirming the suspected
recombination. Growth kinetics showed no significant effect on
virus replication due to insertion of the fluorescent proteins into
ORF63/70 (Fig. 4A). Taken together, our data indicated that
recombination between the IRS and TRS region occurred
frequently in cultured MeWo cells, which resulted in a stable
replacement of IRS or TRS with their respective counterparts,
TRS or IRS, respectively.
v63G/70R infection of NHNP TLAs
Cell-free v63G/70R efficiently infected NHNP TLAs, as
evidenced by an approximate 50-fold increase in VZV genome
copies from 0 to 18 days post-infection (dpi). After 18 dpi, VZV
genome copy numbers remained constant (Fig. 4B). To compare
the overall health of VZV infected MeWo cells grown in 2D to
VZV infected NHNP TLAs grown in 3D, glucose utilization pre-
Figure 1. NHNP TLAs are genetically stable for at least 180 days and form tissue like assemblies. (A) mFISH analysis of passage 1 NHNP
cells (left panel) and (B) NHNP TLAs after 180 days in culture (right panel). Representative metaphase chromosomes labeled with Spectra Vysion Tm
probes are shown. (C–F) Environmental scanning electron micrographs with 1506 (C, D), 6506 (E) and 20006 (F) magnifications illustrate the relative
size, density, and complexity of TLAs. Scale bars are shown in each image.
doi:10.1371/journal.ppat.1003512.g001
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and post-VZV infection was monitored (Fig. 4C). Each culture was
maintained initially for 39 days to establish a baseline glucose
consumption rate. Upon v63G/70R infection, glucose utilization
rapidly declined in MeWo cells, most likely a consequence of lytic
VZV replication as seen microscopically by extensive VZV-
induced cytopathic effects (data not shown). In contrast, glucose
uptake in NHNP TLAs was not altered as a response to VZV
infection (Fig. 4C), suggesting that limited, if any, lytic VZV
infection occurred. Quantitative RT-PCR was performed to
determine if the virus genome was transcribed in infected NHNP
TLAs. Transcript levels of the immediate-early gene ORF63
increased over time and correlated to the amount of VZV genome
copies (Fig. 5A). Further analysis showed that late VZV gene ORF
9 and ORF 40 transcripts also increased in abundance (Fig. 5B).
To determine if infectious virus was released from infected
NHNP TLAs, cell-free supernatants from VZV infected NHNP
TLAs were titrated using permissive MeWo cells and plaques
stained using an anti-VZV IE63 antibody. Shortly after inocula-
tion of the NHNP TLA culture with VZV, high levels of cell-free
virus were detected (Table 2). Each day post infection, 80% of the
culture medium was replaced, resulting in a rapid removal of cell-
free virus from the reactor. However, low-level release of cell-free
VZV was detected on 6, 10, 25 and 35 dpi, while no infectious
virus was detected on 14, 21 and 30 dpi, indicating intermittent de
novo production and release of infectious virus (Table 2). It is
noteworthy that the NHNP TLAs remained intact and healthy
despite apparent virus production.
Confocal analysis of NHNP TLAs infected with VZV contain-
ing eGFP fused to both ORF63 and ORF70 at 27 dpi revealed
that the progenitor neuronal marker Nestin (Fig. 6 A–C) and the
mature neuronal marker b-Tubulin-III colocalized with ORF63-
eGFP (Fig. 6D–F). Taken together, our data demonstrates that
VZV infection of NHNP TLAs results in prolonged accumulation
of virus DNA, mRNA and sporadic release of very small amounts
of infectious cell-free virus.
Stable maintenance of the VZV genome in NHNP TLAs
Recombination between inverted repeat regions in the genome
of alphaherpesviruses during lytic replication is well documented
[20,21]. To determine if VZV DNA recombination occurred in
MeWo (2D) or NHNP TLAs (3D) cultures, we determined the
recombination frequency between ORF63 and ORF70 by qPCR.
During lytic replication in MeWo cells, recombination within the
VZV genome that resulted in a replacement of ORF70-mRFP
with ORF63-eGFP occurred frequently (Fig. 7A), indicating a
selective pressure against the ORF70-mRFP fusion protein. In
contrast, the GFP/RFP ratios in v63G/70R infected NHNP TLAs
remained unaltered for at least 69 days in culture, suggesting that
the VZV genome is stably maintained in NHNP TLAs. In
addition, confocal microscopy confirmed that both ORF63-eGFP
and ORF70-mRFP are expressed in NHNP TLA cultures infected
with v63G/70R (Fig. 7B). Our data indicates a stable viral genome
is preserved for an extended period in NHNP TLAs.
Discussion
Establishment of latent infection and subsequent reactivation is
integral to the alphaherpesvirus life cycle and ensures that virus is
maintained in the population by intermittent virus production and
transmission [22]. However, VZV appears to be unique among
alphaherpesviruses with respect to establishment of and reactiva-
tion from the persistent/latent state [23–26], emphasizing the
need for accurate nomenclature. VZV-host interactions are
classified as acute, ‘‘rapid production of infectious virions followed
by rapid resolution and elimination of infection’’, or persistent,
‘‘virus particles or products continue to be produced for long
periods in which virions are continuously or intermittently
produced’’ [27]. In most human cells in culture, VZV infection
Figure 2. Expression of neuronal markers in NHNP TLAs and
human trigeminal ganglia (TG). (A) The neuronal markers Neuron-
Specific Nuclear Protein (NeuN), Microtubule Associated Protein A&B
(MAP2 A/B), b-Tubulin-III and Glial Fibrillary Acidic Protein (GFAP) were
detected in NHNP TLAs by confocal microscopy (green). Nuclei were
visualized using Alexa Fluor 488 (red). Representative images are shown
at 4006 magnification. (B) Expression of Nestin and b-Tubulin-III in
human TGs at indicated magnification. (C) Expression levels of CXCR4,
CD133, Nestin, CD105, CD90, CD49f and b-Tubulin-III in three primary
TGs (white bars) obtained from two donors or NHNP TLAs (black bars).
Data is shown as mean mRNA copies relative to GAPDH with standard
deviations (error bars).
doi:10.1371/journal.ppat.1003512.g002
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is acute and cells succumb to virus infection within 3–5 days most
likely through apoptosis [28–31]. The low ratio (1:40,000) of
infectious to defective VZV particles indicates that production of
complete virions is extremely inefficient [32]. Human neurons are
known to be latently infected by VZV, but the lack of a suitable
animal model has hindered investigations into this exceptional
relationship between VZV and a host cell or organ. Our common
understanding is that VZV infection of neurons results in latency.
Latency is an extreme variant of persistent infection where, as
exemplified by herpes simplex virus type 1 (HSV-1), ‘‘infectious
virions can no longer be isolated’’ [27]. During latency, most
HSV-1 genes are silenced through epigenetic modification of
resident histones or by virus-specific miRNAs [33–35]. Therefore,
HSV-1 gene transcription in infected neurons is restricted to the
latency-associated transcript (LAT) at the cellular level, while no
viral proteins and infectious virions are produced [36–38].
According to the above definitions and following the example
provided by HSV-1, the prototype alphaherpesvirus, VZV
infection of NHNP TLAs maintained in 3D cultures is persistent
and not latent. While VZV DNA is present and virus-induced
CPE was not detected either microscopically or by monitoring
total glucose uptake, VZV genes are transcribed, IE63 is
translated, and small amounts of infectious virions are intermit-
tently produced. The observation that the quantity of late VZV
transcripts directly correlates to IE63 transcription and viral
genome copies, suggests that many cells could express these
transcripts and potentially produce infectious virus. Alternatively,
late transcripts as well as infectious cell-free virions could be
derived from very few cells that productively replicate VZV. While
at least 12 VZV genes are transcribed in human ganglia removed
at autopsy [39–41] and IE63 protein production is commonly
detected [42], it is known that the extent of VZV transcription
increases with longer times between death and tissue analysis [43].
Hence, it has been argued that transcription of multiple virus
genes detected in human ganglia most likely reflects reactivation of
latent virus genomes [44,45]. Thus, while multiple viral genes are
transcribed in infected NHNP TLAs and in human trigeminal
ganglia containing VZV DNA at autopsy, the former is a long-
term permissive infection and the later most likely reflects early
stage virus reactivation.
Our current work highlights the importance of NHNP TLAs in
3D culture for the study of VZV persistent infection, latency and
reactivation. The ability to maintain VZV infection for extended
times along with the ease of experimental manipulation allows us
to investigate the VZV life cycle in an in vitro system for the first
time. Our 3-month experiment was operator-terminated, and the
healthy cultures still contained VZV DNA. As such, infected
NHNP TLAs in 3D culture provide an excellent means to
investigate chronic virus-neuron interactions. An additional
attribute of the 3D cultures is that they allow introduction of
autologous VZV-specific CD8 T-cells with the aim of immune
surveillance that would remove cells actively producing virus.
Previous studies on HSV-1 showed that CD8 T-cell surveillance
within latently infected human and mouse trigeminal ganglia may
help maintain latent infection [46–56]. This in turn could be also
true for VZV and could allow the establishment of latently infected
NHNP cultures by the addition of CD8 T-cells.
The NHNP TLAs system developed here is based on growth on
inert support microspheres that proliferate and remain viable in a
3D fluid environment using an optimized GTSF-2 medium.
Various TLAs systems have been shown to exhibit morphologies,
growth characteristics, and cytokine expression similar to human
lung, liver, and small intestine [57–62]. Therefore, TLAs provide a
promising platform to model viral infections of human cells in a
3D environment that is similar to the natural tissue. We have
shown previously that human bronchio-tracheal tissue maintained
as 3D-TLAs (HLEMs) can be used to investigate respiratory
syncytial virus (RSV), parainfluenza virus (PIV3) and severe acute
respiratory syndrome (SARS) [57,60,63,64] infections. HLEMs
can be maintained for at least two months and can facilitate the
discrimination between pathogenic and attenuated RSV and PIV3
strains based on viral replication efficiencies and inflammatory
responses. In addition, SARS was shown to replicate for up to two
weeks in HLEMs without TLA destruction [57,63,64]. The
NHNP TLAs we constructed can also be used to investigate other
neurotropic viruses (West Nile, Dengue and Vesicular Stomatitis
Virus [VSV]) [65–66, unpublished data].
As mentioned previously, VZV infection of most human cells
results in acute cell death. This also occurs in neuronal cultures
maintained in 2D, unless they are devoid of non-neuronal cells.
Our 3D neuronal TLA cultures are unique in that VZV infection
did not destroy the tissue-like assemblies even though low amounts
of infectious virus were sporadically released and even when a
mixed neural progenitor cell population was present. In this
respect, neuronal progenitor cell cultures maintained in 3D are
fundamentally different from the same cells maintained in 2D
[17,19]. Therefore, this newly established NHNP TLA 3D system
provides the unique opportunity to investigate neurotropic viruses
in a neuronal setting over extended periods of time.
Table 1. Marker protein expression as measured by flow cytometry demonstrates consistent expression of early progenitor and
neuronal cell markers during the course of the 180 day experiment.
% positive 2-D NHNP % positive 3-D NHNP Marker description
CXCR4 2.0 8.0 neural progenitor marker
CD133 4.0 5.0 primitive neural stem cell/HSC*
CD105 (Endoglin) 98.0 96.0 neural stem cell/MSC**
CD90 (Thy-1) 99.0 91.0 neural progenitor cell/HSC*/MSC**
CD49f (a6 integrin) 98.0 99.0 early progenitor maturation regulated by CD90
CD34 2.0 1.0 early hematopoietic marker (negative control)
CD38 0.0 0.0 cell activation/differentiation (negative control)
*HSC: hematopoietic stem cells.
**MSC: mesenchymal stem cells.
doi:10.1371/journal.ppat.1003512.t001
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Materials and Methods
NHNP TLA 3D cell culture system
NHNP cells were obtained from Lonza (Walkersville, MD,
USA) and propagated in GTSF-2, a unique media containing
glucose, galactose and fructose supplemented with 10% fetal
bovine serum (FBS), at 37uC under a 5% CO2 atmosphere [67–
69]. NHNP cells were initially grown as monolayers in human
fibronectin-coated flasks (BD Biosciences, San Jose, CA) and
pooled from at least five donors, as described previously [70].
NHNP cell cultures were expanded, tested for viral contaminants
as pre-certified by the manufacturer’s production criteria (Lonza),
and cryopreserved in liquid nitrogen. Three-dimensional (3D)
NHNP TLAs were generated by seeding 36105 NHNP cells/ml
onto 3 mg/ml Cultispher beads (Sigma-Aldrich, St. Louis, MO)
into a 55 ml rotating wall vessel bioreactor (RWV; Synthecon,
Houston, TX) and grown at 37uC under a 5% CO2 atmosphere.
Cells were allowed to attach to the beads for 48 h in the bioreactor
before re-feeding with GTSF-2 containing 10% FBS. To maintain
the TLA cultures within normal human physiological blood
chemistry parameters (pH 7.2 and a glucose concentration of 80–
120 mg/dL), 20–90% of the media was replaced as required with
fresh GTSF-2 media every 48 h, facilitating efficient TLA tissue
growth and maturation prior to VZV infection. All metabolic
determinations were made using an iStat hand held blood gas
analyzer (Abbott Laboratories, Abbott Park, IL).
Figure 3. Generation of fluorescently labeled VZV P-Oka facilitates analysis of ORF63 and ORF70 expression. (A) Schematic
representation of the VZV genome with a focus on the regions containing ORF63 and ORF70. Insertion of eGFP (green arrow) and mRFP (red arrow) at
the C-terminus of ORF63 and ORF70 are indicated respectively. (B) Restriction fragment length polymorphism (RFLP) analysis of parental pP-Oka (lane
1 and 3) and p63G/70R (lane 2 and 4) BAC DNA digested with indicated enzymes. Green and red asterisks indicate fragments containing ORF63 and
ORF70 respectively that increase in size upon insertion of eGFP and mRFP. (C) Florescence microscopy images of VZV plaques detecting ORF63-eGFP
and ORF70-mRFP expression after BAC DNA transfections (upper panel) and upon passaging of the virus (middle and lower panel).
doi:10.1371/journal.ppat.1003512.g003
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Propagation of MeWo cells and VZV
Human melanoma cells (MeWo, American Type Culture
Collection, ATCC, Manassas, VA.) were propagated in Dulbec-
co’s minimal essential medium supplemented with 10% fetal
bovine serum, 100 U/ml penicillin and 0.1 mg/ml streptomycin
(Sigma-Aldrich, St. Louis, MO) at 37uC under 5% CO2 [71].
Wild-type and recombinant viruses were passaged on MeWo cells
by co-cultivation of infected with uninfected cells at a ratio of 1/5
[72]. MeWo cells for the infection of NHNP cultures were adapted
to GTSF-2 medium over two passages prior to harvest of VZV.
Preparation of cell-free VZV
Cell-free VZV [73] was used for the NHNP TLA infections to
avoid transfer of infected MeWo cells to the TLA culture. Briefly,
infected cells were harvested at 96 h post-infection (p.i.) and
resuspended in reticulocyte standard buffer (10 mM NaCl,
1.5 mM MgCl2, 10 mM Tris-HCl, pH 7.4). Cells were disrupted
by Dounce (type A) homogenization (Cole-Parmer, Vernon Hills,
Figure 4. v63G/70R replicates comparable to parental virus in
vitro. (A) Replication kinetics of parental P-Oka (rOKA) and v63G/70R in
MeWo cells. Data is shown as mean viral titers with standard deviations
(error bars). (B) Replication of v63G/70R in NHNP TLAs. NHNP TLAs were
infected with v63G/70R in triplicate, samples removed at the indicated
time points and analyzed by qPCR. Data is shown as mean viral genome
copies with standard deviations (error bars). (C) Daily glucose utilization
of MeWo cells and NHNP TLAs prior and post infection with v63G/70R at
day 39. Passages of MeWo cells are indicated with an arrow. Data is
shown as mean glucose utilization levels with standard deviations (error
bars).
doi:10.1371/journal.ppat.1003512.g004
Figure 5. VZV gene transcription in infected NHNP TLAs. Two
independent NHNP TLAs were established, infected with v63G/70R and
sampled at indicated times post infection. A) qPCR analysis of VZV DNA
genome copies (dORF63) and qRT-PCR of ORF63/70 transcript copies
(tORF63) normalized against corresponding GAPDH copies. (B) qRT-PCR
analysis of VZV ORF40 (tORF40) and ORF9 (tORF9) transcript copies
normalized against GAPDH mRNA copies. Data of two independent
experiments analyzed in triplicate is shown as mean relative copies and
was analyzed using DDCt analyses.
doi:10.1371/journal.ppat.1003512.g005
Persistent VZV Infection in NHNP TLAs
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IL), debris removed by centrifugation at 9006g for 15 min and
virus containing supernatant filtered using a 1.0 mm Millex filter
unit (Millipore Billerica, MA.).
Infection of 3D NHNP TLA cultures
NHNP TLAs were infected in the RWV with cell-free VZV at a
multiplicity of infection (MOI) of 0.1 by absorption at room
temperature for 30 min in 20 ml GTSF-2. Then, the RWVs were
filled with fresh GTSF-2/10% FBS and transferred to a
humidified incubator with a 5% CO2 atmosphere at 37uC. Every
24 h.p.i., ,80% of the culture media was replaced with fresh
GTSF-2 containing 10% FBS. Samples were collected approxi-
mately every other day for ,70 days to determine viral genome
copies as described below. Supernatant of infected NHNP TLAs
was removed, centrifuged to remove cells and debris and titrated
in fresh MeWo cells to determine the amount of infectious VZV
virions in the NHNP culture media.
Metaphase fluorescence in situ hybridization (mFISH)
analysis
Multicolor mFISH for the analysis of chromosome integrity was
conducted as described [74,75]. Briefly, NHNP cells and TLAs
were cultured as previously stated, with the exception of being
subcultured at a low density for 36 h. Cultures were incubated for
20 min with 50 nM calyculin-A (Waco Chemicals, Japan), treated
with 0.075 M KCl hypotonic solution at 37uC for 20 min, fixed in
methanol/acetic acid (3:1 vol/vol) and stored at 220uC.
Chromosome spreads were prepared as described [76,77].
Chromosome-containing slides were hybridized with Spectra
Vysion Tm probes (Vysis, Downers Grove, IL) to detect specific
chromosome pairs. Chromosomes were stained with DAPI and
analyzed using a Zeiss Axioplan fluorescence microscope.
Environmental scanning electron microscopy
Sample preparation, scanning and analysis of the TLAs was
performed as described previously [78,79]. Images of NHNP
TLAs were taken using a Philips XL 30 ESEM (FEI Co.,
Hillsboro, OR), at 1506, 6506 and 20006 magnifications to
illustrate the complexity and the tissue–like nature of the cultures.
Confocal and flow cytometry analyses
Neuronal markers were detected by indirect immunofluores-
cence using anti-human CXCR4, CD133, Nestin, CD105
(Endoglin), CD90 (Thy-1) CD49f (ITGa6) and b-Tubulin-III at
the following dilutions: CXCR4 50 mg/ml, CD133 25 mg/ml,
Nestin 50 mg/ml, CD105 Endoglin 50 mg/ml, CD90 Thy-1
50 mg/ml, CD49f (ITGa6) 25 mg/ml, b-Tubulin-III 25 mg/ml,
Table 2. Release of infectious virus into VZV infected NHNP
TLA tissue culture fluid.
days post infection plaque forming units per ml (5 wells)
1 2 3 4 5
0 371 351 207 402 457
2 5 2 2 1 2
4 3 0 0 2 2
6 1 2 2 2 1
10 0 1 0 0 2
14 0 0 0 0 0
21 0 0 0 0 0
25 2 1 1 3 2
30 0 0 0 0 0
35 0 0 1 1 0
doi:10.1371/journal.ppat.1003512.t002
Figure 6. Infected NHNP TLA cells express progenitor and mature neuronal markers. NHNP TLAs were infected with v63G/70R, fixed 21
days post-infection and stained for the progenitor marker Nestin (upper panels, A–C) and the mature marker b-Tubulin-III (lower panels, D–F).
Representative confocal images are shown at 406magnification. The outline of the TLAs (white line) and scale bars are indicated.
doi:10.1371/journal.ppat.1003512.g006
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CD34+ 25 mg/ml, and CD38 25 mg/ml. All reagents were
obtained from R&D Systems (Minneapolis, MN.) with the
exception of CXCR4 obtained through ABCAM (Cambridge,
MA.). Confocal and flow cytometry used the same reagents and
confocal analyses were performed as described previously
[57,60,80]. Flow cytometry followed the method of Morrison et
al. [81] with minor modifications. Briefly, NHNP TLAs from
RWV culture vessels were collected into a 50 mL conical tube and
dissociated in 15 mL of 2% trypsin for ,5 min, just long enough
to dislodge cells. Trypsin was inactivated with 35 mL cold 10%
FBS in PBS. Culture beads were allowed to sediment and free
floating cells were transferred into a fresh conical tube, washed
twice in PBS, centrifuged for 3 min at 6006g. The soft cell pellet
was resuspended in GTSF-2 and permitted to recover for 1 h at
37uC. After recovery, viable cells (trypan blue exclusion) were
counted and aliquots (,16105) were washed 26 in PBS and used
for flow cytometry. Fluorochromes were added and incubated
45 min at 4uC in PBS, washed 26 in PBS at 4uC and brought to
400 mL with PBS. All analysis was done on freshly conjugated
cells. Samples were either analyzed by confocal microscopy on a
Leica TCS/SP2 3-laser confocal microscope or a Beckman
Coulter XL2 Flow Cytometer (Table 1).
Human trigeminal ganglia and immunohistochemistry
Collection and use of human cadaver tissue was approved by
the University of Colorado Internal Review Board and removed
only after obtaining informed consent from next-of-kin (Multi
Institution Review Board Document No. B182). Harvest of
cadaver tissues is not considered human research as determined
by the IRB. Trigeminal ganglia were fixed in 4% paraformalde-
hyde overnight, dehydrated through graded ethanol, and embed-
ded in paraffin. Five micrometer sections were collected on
Superfrost (Cole-Parmer, Vernon Hills, IL) slides and fixed at
72uC for 30 min. Samples were deparaffinized in xylene and
rehydrated in graded ethanol. Antigen was retrieved by soaking
the sections in 10 mM sodium citrate (pH 6.0) in a steamer for
25 min. Slides were blocked in 5% normal goat serum for 1 h at
room temperature and then incubated with mouse anti-Nestin
monoclonal (1:1,000 dilution; BD Transduction Labs, San Jose,
CA) or mouse anti-b-Tubulin-III monoclonal (1:200 dilution; Cell
Signaling, Danvers, MA) antibody overnight at 4uC. Slides were
washed in PBS and biotin-conjugated goat anti-mouse IgG
(1:1,000 dilution; Dako, Carpinteria, CA) was applied for 1 h at
room temperature. After secondary antibody application, slides
were PBS washed and incubated with diluted alkaline phospha-
tase-conjugated streptavidin (BD Biosciences, San Diego, CA) for
1 h. The color reaction was developed for 2 min using the fresh
fuchsin substrate system (Dako, Carpinteria, CA) in the presence
of levamisole at a final concentration of 24 mg/ml. All images were
acquired using Axiovision (Zeiss) digital imaging software with a
Nikon Eclipse E800 microscope.
Nucleic acid quantification
DNA and RNA were extracted from cell pellets using DNeasy
and RNeasy kits according to manufacturer’s protocol (Qiagen,
Valencia, CA). Complementary DNA was synthesized from
100 ng of DNase-treated RNA using the Transcriptor System
(Roche Diagnostics, Mannheim, Germany) as previously described
[82]. Specific primers and probes for TaqMan and SYBR PCR
were obtained from IDT (Cedar Rapids, IW) to quantify VZV
ORF9, ORF 40, ORF 63/70 and the cellular GAPDH gene. To
differentiate between VZV DNA and transcripts containing eGFP
or mRFP fused to the 39-end of ORF63/70, we used specific
primers and probes for each target (Table 3). PCR amplification
using the 7500-Fast real-time PCR system (Applied Biosystems,
Foster City, CA) was previously described [83]. All primers and
probes are shown in Table 3.
Fluorescence tagging of VZV ORF63/70
VZV ORFs 63 and 70 were C-terminally labeled with the
enhanced green fluorescent protein (eGFP) or the monomeric red
fluorescent protein (mRFP) (Fig. 5A) using two-step Red-mediated
en passant mutagenesis as described [84]. Briefly, the eGFP-I-SceI-
Figure 7. The VZV genome is genetically stable in infected
NHNP TLAs. (A) MeWo cells and NHNP TLAs were infected with v63G/
70R and propagated for the indicated time frames. Infected MeWo cells
were passaged every 3–4 days, while infected NHNP TLAs were
maintained by the replenishment of medium as required. At indicated
time points, samples from the infected MeWo cells and NHNP TLAs
were removed, total DNA extracted and DNA copies of ORF63-eGFP and
ORF70-mRFP determined by qPCR. Data are shown as mean ratio of
ORF63-eGFP to ORF70-mRFP determined in triplicate from two
independent experiments in MeWo cells and 4 independent NHNP
TLAs. (B) ORF63-eGFP and ORF70-mRFP expression (upper row) in a
representative NHNP TLA at 27 days post infection with v63G/70R. An
overlay of eGFP and mRFP fluorescence as well as a bright field image
(lower row) of the NHNP TLA is shown at 406magnification.
doi:10.1371/journal.ppat.1003512.g007
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aphAI and mRFP-I-SceI-aphAI cassette was amplified from pEP-
eGFP-in and pEP-mRFP-in, respectively [84,85] with specific
primers (Table 3). PCR products were introduced into pP-Oka, an
infectious BAC clone of the P-Oka strain of VZV [86,87] by Red
recombination performed in GS1783 E.coli cells (a kind gift from
Gregory A. Smith, Northwestern University, Chicago, IL). All
clones were confirmed by DNA sequencing using primer sets
specific for either ORF63 or ORF70, as well as multiple restriction
fragment length polymorphism analyses (RFLP), to ensure the
integrity of the genome (Fig. 5B).
Reconstitution of VZV from BAC DNA
Recombinant BAC DNA used for transfection was isolated
using the plasmid Midi-prep kit according to the manufacturer’s
instruction (Qiagen, Valencia, CA). MeWo cells were transfected
with the Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA) as






ORF63 seq for CCTGGTTACCCAGGCCGTGC
rev GAGCGATACGCGGGTGCAG





CD105 (Endoglin) for CCGCGCTTCAGCTTCCT
rev GAGGGTGCCGGTTTTGG




CD133 (PROM1) for ATCTGCAGTGGATCGAGTTCTCT
rev GCGGTGGCCACAGGTTT
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described [88]. Briefly, MeWo cells were transfected with 1 mg
BAC DNA and 200 ng pCMV62, a plasmid that contains the
VZV IE gene ORF62 under the control of the human
cytomegalovirus immediate-early promoter (kindly provided by
Dr. Paul Kinchington, University of Pittsburgh Medical School).
Reconstituted viruses were propagated on MeWo cells as
described above and analyzed for expression of the
ORF63GFP/70RFP fusion proteins using a Zeiss Axiovert 25
fluorescence microscope system. In addition, VZV containing
fluorescent tags at the C-terminus of both ORF63 and ORF70
upon recombination in MeWo cells was plaque purified and some
viruses contained only either the eGFP or mRFP tag after plaque
purification as shown by PCR and DNA sequencing analysis.
Growth kinetics of VZV
MeWo cells (16106) were inoculated with 100 plaque-forming
units (pfu) of cell-associated virus. Infected cells were trypsinized at
24, 48, 72 or 96 h post infection (h.p.i.), titrated in 10-fold
dilutions, and added to MeWo cell monolayers seeded 24 h
before. The number of plaques was determined by indirect
immunofluorescence using an anti-VZV antibody exactly as
described earlier [89].
3D TLA growth kinetics and glucose consumption
Metabolic parameters of infected and uninfected NHNP TLAs
were measured every 24 h over the course of the experiments to
monitor a cellular development profile and to monitor the
metabolic status of the tissues. Glucose consumption was
determined using the iStat clinical blood gas analyzer using an
EC8+ cartridge (Abbott Laboratories, Abbott Park, IL) according
to the manufacturer’s instructions [60].
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